dual gip glp 1 receptor agonists Efficacy and safety of LY3298176, a novel and GLP-1 agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial PDF] Novel dual GLP-1/GIP receptor
Pay in 4 interest-free payments of $5.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
![dual gip glp 1 receptor agonists Efficacy and safety of LY3298176, a novel and GLP-1 agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial PDF] Novel dual GLP-1/GIP receptor](https://figures.semanticscholar.org/d83a64f6b7193358c31030487761fc19c80dd33c/3-Figure1-1.png)
![dual gip glp 1 receptor agonists Efficacy and safety of LY3298176, a novel and GLP-1 agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial PDF] Novel dual GLP-1/GIP receptor](https://vertassets.blob.core.windows.net/image/985547fe/985547fe-83f8-4d12-a0f3-0b6bb4a35678/glp1_timeline_chart_large.jpg)
![dual gip glp 1 receptor agonists Efficacy and safety of LY3298176, a novel and GLP-1 agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial PDF] Novel dual GLP-1/GIP receptor](https://images.everydayhealth.com/images/diet-nutrition/obesity/consumer-guide-glp1-obesity-header-update-1-22-1440-x810.jpg?sfvrsn=b97b854_1)
![dual gip glp 1 receptor agonists Efficacy and safety of LY3298176, a novel and GLP-1 agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial PDF] Novel dual GLP-1/GIP receptor](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00592-024-02300-6/MediaObjects/592_2024_2300_Fig1_HTML.png)
![dual gip glp 1 receptor agonists Efficacy and safety of LY3298176, a novel and GLP-1 agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial PDF] Novel dual GLP-1/GIP receptor](https://ars.els-cdn.com/content/image/1-s2.0-S0968089624000440-ga1.jpg)















